Ironwood Pharmaceuticals reported $27.74M in Selling and Administration Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 81.67M 15.12M
Acceleron Pharma XLRN:US $ 45.11M 9.64M
Agios Pharmaceuticals AGIO:US $ 27.15M 2.06M
Akebia Therapeutics AKBA:US $ 46.36M 4.71M
Alnylam Pharmaceuticals ALNY:US $ 142.07M 11.75M
Amarin AMRN:US 102.96M 4.24M
Ardelyx ARDX:US $ 17.31M 2.81M
Astellas Pharma 4503:JP 133.4B 3.71B
Astrazeneca AZN:US 2.99B 412M
AstraZeneca AZN:LN 2.99B 412M
Bluebird Bio BLUE:US $ 68.28M 10.3M
Charles River Laboratories CRL:US $ 148.57M 19.31M
Coherus Biosciences CHRS:US $ 39.92M 420K
Emergent Biosolutions EBS:US $ 82.1M 9.1M
Esperion Therapeutics ESPR:US $ 39.26M 7.05M
Exact Sciences EXAS:US $ 383.16M 20.7M
Flexion Therapeutics FLXN:US $ 26.99M 423K
Halozyme Therapeutics HALO:US $ 13.17M 848K
Intercept Pharmaceuticals ICPT:US $ 53.34M 4.32M
Ironwood Pharmaceuticals IRWD:US $ 27.74M 690K
Karyopharm Therapeutics KPTI:US $ 35.1M 1.43M
Lexicon Pharmaceuticals LXRX:US 7.3M 633K
Macrogenics MGNX:US $ 17.16M 1.93M
Moderna Inc MRNA:US 168M 47M
Myriad Genetics MYGN:US $ 180.2M 45.4M
Pacira Pharmaceuticals PCRX:US $ 48.81M 2.01M
Ptc Therapeutics PTCT:US $ 69.25M 374K
Puma Biotechnology PBYI:US $ 26.08M 13.33M
Sarepta Therapeutics SRPT:US $ 61.13M 11.22M
Takeda 4502:JP 212.01B 7.83B
Ultragenyx Pharmaceutical RARE:US $ 53.88M 473K
Vanda Pharmaceuticals VNDA:US $ 32.46M 4.11M
YTE INCY:US $ 190.7M 21.84M